NEW YORK (360Dx) – During the past year, researchers developing diagnostic tests that detect and analyze disease markers within exosomes reported progress with creating more promising techniques to isolate the exosomes prior to their measurement by liquid biopsy test systems. In so doing, they have pushed their exosome diagnostic tests closer to commercialization

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.